socalTECH
SEPTEMBER 28, 2017
According to the two, AbbVie will grant a patent license for use and sale of the compound worldwide, on a country-by-country basis. As a result of the settlement, Amgen said it expects to launch its product in Europe in October of 2018, and its product for the United States in 2023.
Startup Professionals Musings
SEPTEMBER 15, 2023
Tesla has found that sharing many of their battery patents has expanded the market for all electric vehicle providers, as well as attracted the very best engineers to join Tesla’s team. Marty Zwilling First published on Inc.com on 08/31/2023 This usually requires a new paradigm, real creativity, or dramatic innovation.
Expert insights. Personalized for you.
100 
Let's personalize your content